Skip to main content

Table 3 Biochemical assessment of between studied groups (n = 120)

From: Evaluation of platelets activity and reactivity as risk factors for acute ischemic non-embolic stroke in young adults

Laboratory investigations

Patients without risk factors (A1) (n = 37)

Patients with risk factors (A2) (n = 23)

Healthy controls (n = 60)

Test value

p-value

Post hoc between A1 and A2

RBS (mg/dl)

Mean ± SD

115.6 ± 52.7

145.6 ± 87.2

110.1 ± 28

F = 3.98

0.02*

0.049*

Range

81–218

75–379

74–188

Creatinine (mg/dl)

Mean ± SD

0. 74 ± 0.2

0.88 ± 0.2

0.59 ± 1.6

F = 12.2

< 0.001*

0.02*

Range

0.3–1.2

0.5–2

0.3–1

Total cholesterol (mg/dl)

Mean ± SD

174.2 ± 38.7

194.1 ± 49.9

138.8 ± 52.2

F = 12.7

< 0.001*

0.28

Range

93–224

103–313

55–215

TG (mg/dl)

Mean ± SD

125.4 ± 51.7

165.8 ± 82.5

98.3 ± 31.9

F = 14.3

< 0.001*

0.01*

Range

47–262

66–324

54–201

LDL (mg/dl)

Mean ± SD

110.5 ± 36.6

124.2 ± 48.3

95.1 ± 27.6

F = 6.1

0.003*

0.35

Range

39–224

51–233

45–164

HDL (mg/dl)

Mean ± SD

35.5 ± 8.7

36.9 ± 7.9

32.7 ± 8.7

F = 2.37

0.098

0.83

Range

13–54

25–60

12–51

  1. *One-way ANOVA (analysis of variance) is statistically significant at level of significance of 95%. (p < 0.05). RBS random blood sugar, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein
  2. bold indicates statistically significant relation
  3. italic indicates the type of the test used